In SCLC, for instance, the KCNJ2/Kir2.1 channel is expressed in 44.23% of tissues and influences cell growth and drug resistance by regulating the expression of MDR protein 1 (MRP1/ABCC1). This evidence concerns the gene KCNJ2 and small cell lung carcinoma.